GetTopicDetailResponse(id=19ba2265018, topicName=臨床, introduction=臨床, content=null, image=null, comments=0, allHits=2368, url=https://h5.medsci.cn/topic?id=22650, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=313, tagList=[TagDto(tagId=313, tagName=臨床)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2185455, encodeId=e1a6218545529, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#腫瘤#</a> <a href='/topic/show?id=19ba2265018' target=_blank style='color:#2F92EE;'>#臨床#</a> <a href='/topic/show?id=262fe9723bd' target=_blank style='color:#2F92EE;'>#美國臨床腫瘤學會#</a>, objectTitle=禮進生物將在2023?ASCO上報告4-1BB激動劑臨床成藥性突破, objectType=article, longId=773755, objectId=f383e737553d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230526/1685066660447_5444305.png, objectUrl=/article/show_article.do?id=f383e737553d, replyNumber=0, likeNumber=111, createdTime=2024-02-02, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=f383e737553d, moduleTitle=禮進生物將在2023?ASCO上報告4-1BB激動劑臨床成藥性突破, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f383e737553d)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話題小助手
2020-05-29
